ovarian hyperstimulation (COH) and intrauterine
|
|
- Ronald Terry
- 5 years ago
- Views:
Transcription
1 No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination Erika Werbrouck, M.D., Carl Spiessens, Ph.D., Christel Meuleman, M.D., and Thomas D Hooghe, M.D., Ph.D. Leuven University Fertility Centre, University Hospital Leuven, Leuven, Belgium Objective: The association between infertility and minimal to mild is controversial and poorly understood. The clinical pregnancy rate (PR) per cycle after controlled ovarian hyperstimulation (COH) with or without intrauterine insemination (IUI) is reportedly lower in women with surgically untreated minimal to mild than in women with unexplained infertility. It is possible that prior laparoscopic removal of has a positive effect on the clinical PR after COH and IUI. Therefore, we tested the hypothesis that after COH and IUI the PR per cycle and the cumulative live-birth rate (CLBR) are equal or higher in women with recently surgically treated minimal to mild when compared with women with unexplained infertility. Design: A retrospective, controlled cohort study. Setting: Leuven University Fertility Centre, a tertiary academic referral center. Patient(s): One hundred seven women treated during 259 cycles with COH and IUI including patients with (n 58, 137 cycles) and unexplained infertility (n 49, 122 cycles). All patients with had minimal (n 41, 100 cycles) or mild (n 17, 37 cycles) disease that had been laparoscopically removed within 7 months before the onset of treatment with COH and IUI. Intervention(s): Controlled ovarian hyperstimulation using clomiphene citrate (23 cycles) or gonadotrophins (236 cycles) in combination with IUI. Main Outcome Measure(s): Clinical PR per cycle and CLBR within four cycles of treatment with COH and IUI. Result(s): The clinical PR per cycle was comparable in women with minimal or mild (21% or 18.9%, respectively) and in women with unexplained infertility (20.5%). The CLBR within four cycles of COH and IUI was also comparable in women with minimal, mild, and unexplained infertility (70.2%, 68.2 %, 66.5%, respectively). Conclusion(s): The data from our study suggest that COH and IUI shortly after laparoscopic excision of is as effective as COH and IUI in patients with unexplained subfertility. (Fertil Steril 2006;86: by American Society for Reproductive Medicine.) Key Words: Intrauterine insemination, controlled ovarian hyperstimulation, minimal to mild, unexplained infertility Until today, the association between minimal to mild (American Society for Reproductive Medicine [ASRM] [1]) and subfertility has been controversial. In a recent prospective cohort study (2), the probability of conceiving naturally and carrying a pregnancy beyond 20 weeks was approximately 50% lower in women with surgically untreated minimal to mild (15.7%) than in women with unexplained infertility (23.6%). In addition, other retrospective studies have indicated a lower monthly Received September 13, 2005; revised and accepted January 23, Reprint requests: T. D Hooghe, Leuven Unversity Centre, UZ Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium (FAX: ; thomas.dhooghe@uz.kuleuven.ac.be). fecundity rate (MFR) in women with minimal to mild than in women with unexplained infertility (3). Although more prospective studies are needed to confirm and understand the mechanism of subfertility associated with minimal to mild, many investigators have now accepted this association and have tested the hypothesis that -related infertility can be treated by surgery or by nonspecific fertility-enhancing therapy, including controlled ovarian hyperstimulation (COH) and intrauterine insemination (IUI). The hypothesis that surgical removal of minimal to mild improves fecundity has been confirmed by some (4, 5) but not by all (6, 7) investigators in mostly 566 Fertility and Sterility Vol. 86, No. 3, September /06/$32.00 Copyright 2006 American Society for Reproductive Medicine, Published by Elsevier Inc. doi: /j.fertnstert
2 retrospective controlled studies. Recently, in a randomized, controlled Canadian trial, the hypothesis was confirmed that laparoscopic resection or ablation of minimal to mild and associated adhesions enhances fecundity (8). In this study, the MFR and clinical pregnancy rate (PR) after 36 weeks were twice as high after surgical removal of the and associated adhesions (4.7% and 30.7%, respectively) than after diagnostic laparoscopy (2.4% and 17.7%, respectively). According to two prospective, randomized controlled trials, nonspecific fertility enhancement using COH and IUI reportedly improves the monthly live-birth rate (11%) when compared with expectant management (2%) in women with minimal to mild (9, 10). However, not all women had received an ablation of the endometriotic lesions before COH and IUI, and treatment with COH and IUI did not restore normal fertility in these women. In contrast, recently randomized, controlled trials indicated that the clinical PR after COH and IUI (11) or after COH only (12) was significantly lower in women with minimal to mild (13% and 6.5%, respectively) than in women with unexplained infertility (32% and 15%, respectively). However, in both randomized trials, had not been treated surgically before the onset of treatment with COH and IUI. It is possible that treatment with COH and IUI after surgical removal of may result in a higher clinical PR after COH and IUI than treatment with COH and IUI in women with surgically untreated. Therefore, the aim of the present study was to test the hypothesis that the clinical pregnancy (live-birth) rate per cycle, and the cumulative pregnancy (live-birth) rate after COH and IUI are similar or higher in patients with previously surgically removed minimal to mild when compared with women with unexplained infertility. MATERIALS AND METHODS Patient Selection All couples with unexplained infertility or minimal to mild who participated in our program of COH and IUI between 1994 and 2002 were identified from the database of the Leuven University Fertility Center (LUFC). Because the study was of a retrospective nature and all files were searched electronically, it was not necessary to ask for Institutional Review Board (IRB) approval according to the guidelines of the Commission for Medical Ethics in our hospital. In all patients, a complete workup, including surgery, was performed within a period of 3 to 4 months after the initial visit and before the waiting period of 6 to 12 months, allowing spontaneous conception before the onset of treatment with COH and IUI. The complete infertility investigation at LUFC included a semen analysis; basal body temperature records; basal hormonal analysis between day 3 and day 5 of the cycle for FSH, LH, E 2, prolactin, TSH, and androgens; midluteal endometrial biopsy or P analysis; hysteroscopy; and laparoscopy. Three patients had received 1 treatment cycle with COH and IUI in another fertility center before being fully investigated at LUFC. Patients with unexplained infertility were defined as couples with infertility associated with normal results for all previously mentioned diagnostic investigations, with the exception of luteal insufficiency. Patients with minimal to mild were similar to patients with unexplained infertility, except for the presence of endometriotic lesions that were staged as minimal to mild according to the ASRM classification system (1). Patients with minimal or mild had a score of 1 5 or 6 15 points, respectively, as defined in the revised ASRM classification (1).These endometriotic lesions were all excised or destroyed by laser surgery during the diagnostic laparoscopy. Histological confirmation of (i.e., presence of endometrial glands and stroma) was confirmed in all patients in 1 biopsy. Luteal insufficiency was present if the histological dating of the endometrial biopsy was 2 days out of phase (13) or if midluteal P concentration was 10 ng/ml. Patients who conceived naturally after laparoscopy and therefore did not participate in the program of COH and IUI were not followed up in our center; thus, their number is not known. Exclusion criteria included abnormal tuboovarian anatomy compromising tubal transport of gametes or embryos or fimbrial oocyte pickup function (dense adnexal and/or ovarian adhesions due to pelvic inflammatory disease because of previous pelvic surgery for the treatment of moderate or severe ), abnormal ovulatory function (anovulation or oligoovulation due to polycystic ovary syndrome, hyperprolactinemie, thyroid dysfunction, or luteinized unruptured follicle syndrome), abnormal implantation due to endometrial polyps or submucosal myomas, and male factor infertility (semen analysis with 50% progressive motility and/or spermatozoa/ml and/or 10% normal sperm morphology, according to previously reported guidelines (World Health Organization [WHO] [14, 15]). In contrast with the male exclusion criteria, no hard cutoff values were used for the female exclusion criteria because they were based on the medical diagnosis for each patient immediately after the infertility investigation including hysteroscopy and laparoscopy. This diagnosis was based on generally accepted causes for female infertility (16). Using the previously mentioned inclusion and exclusion criteria, we identified 107 patients who were treated during 259 cycles of COH with IUI. Because this was a retrospective cohort study evaluating pregnancy outcome after fertility treatment, neither specific approval by the IRB nor informed consent by the patients was needed. The detailed characteristics of patients and cycles are presented in Table 1. Fertility and Sterility 567
3 TABLE 1 Patient characteristics. Characteristic Minimal Mild Unexplained infertility No. of patients Age (y) No. of insemination cycles No. with primary subfertility (%) 82 (82) 33 (89) 72 (59) No. with secundary subfertility (%) 18 (18) 4 (11) 50 (41) No. with LI Time interval between cycles (years) Duration of subfertility (years) Time interval laparoscopy/first IUI (years) No. of CC cycles Start-dose (mg) No. of hmg cycles Start-dose (N ampuls 75 IU per day) No. of follicles Endometrial thickness (mm) Note: Values are means SD. CC clomiphere citrate; hmg human menopausal gonadotropin; LI luteal insufficiency. Werbrouck. COH and IUI are effective in. Fertil Steril Controlled Ovarian Hyperstimulation The COH in preparation for IUI was performed either with clomiphene citrate (CC), in a dose of 50 or 100 mg/d from day 3 to day 7 of the menstrual cycle (n 23 cycles), or with human menopausal gonadotropin (hmg) in a dose of 75 or 150 IU IM/d (Humegon, Organon, Oss, the Netherlands or Metrodin HP, Serono, Geneva, Switzerland) starting day 2 of the cycle (n 236 cycles). Ovarian response was monitored by ultrasound and blood sampling for E 2, P, LH, and FSH. Human chorionic gonadotropin in a dose of 5,000 or 10,000 IU IM was administered when the leading follicle had reached an average diameter of mm. An IUI was performed approximately 38 hours later. When the women had two or more mature follicles ( 14 mm) at the time of hcg injection, selective follicle aspiration was offered to them, and usually one or two mature follicles were left intact after this procedure. Sperm Analysis and Preparation The semen was collected by masturbation after 3 to 5 days of sexual abstinence. A semen analysis was performed following the WHO guidelines (14, 15). After liquefaction, sperm samples were centrifuged over a discontinuous two-layer density gradient (40%/80%) (Percoll, Amersham Pharmacia Biotech SA, Uppsala, Sweden or PureSperm, Nidacon International AB, Göteborg, Sweden) followed by one wash with HEPES-buffered Earle s Balanced Salt Solution supplemented with 0.3% human serum albumin (Sigma Chemical Co., St Louis, MO) and a second wash using IVF medium (MediCult, Copenhagen, Denmark). The samples were resuspended in IVF medium and subsequently incubated at 37 C and 5% CO 2. After 1 hour, the motility was evaluated and the sperm count was determined. The samples were centrifuged just before insemination, and the pellets were resuspended in a volume of 0.25 ml IVF medium. Intrauterine Insemination The IUI was performed using an intrauterine catheter (Kremer Delafontaine; Prodimed, Neuilly-en-Thelle, France) with a 1- or 2-mL syringe. The catheter was gently passed through the cervical canal, and the sperm suspension was expelled into the uterine cavity. Insemination volumes ranged from ml. The women remained supine for 20 minutes after IUI. A pregnancy test on blood was performed 12 days after IUI. If the test was positive, the pregnancy was confirmed by ultrasonography 3 weeks later. Pregnancies were followed up for the occurrence of miscarriage, ectopic pregnancy, multiple pregnancy, and live birth. Statistical Analysis On the cycle level, pregnancy outcome was defined as clinical PR (presence of a gestational sac on ultrasound at 7 weeks of amenorrhea), implantation rate (number of embryos with positive fetal heart rate on ultrasound), and livebirth rate per cycle of COH and IUI. Differences in these endpoints between groups were statistically evaluated by the 2 test. The cumulative live-birth rate (CLBR) within four 568 Werbrouck et al. COH and IUI are effective in Vol. 86, No. 3, September 2006
4 FIGURE 1 Classification of patients with minimal to mild. Werbrouck. COH and IUI are effective in. Fertil Steril cycles of COH and IUI was analyzed using life table analysis, and subgroups were compared using Kaplan-Meier analysis. RESULTS General Patient Characteristics General patient group characteristics (107 women, 259 cycles) and the distribution of scoring points (5) among the patients with minimal to mild are listed in Table 1 and Figure 1, respectively. The subgroups with minimal, mild, and unexplained infertility were similar, except for the duration of infertility, which was significantly lower in women with unexplained infertility compared with women with minimal (P.0053). None of the patients developed ovarian hyperstimulation. Cycle Level The average clinical PR per cycle was 20.4% and was similar in women with minimal (21%), mild (18.9%), and unexplained infertility (20.5%) (Table 2). The results were also similar between groups for all the other clinical outcome data (Table 2). Life Table Analysis The cumulative live-birth rate within four cycles was similar in patients with minimal (70.2%), mild (68.2%), and unexplained infertility (66.5 %) (Fig. 2). A spontaneous pregnancy occurred during the time interval between two treatment cycles with COH and IUI in six couples with minimal (n 3), mild (n 1), and unexplained infertility (n 2). These pregnancies were not included in the life table analysis. DISCUSSION The results of our study confirm our hypothesis that, after COH and IUI, the clinical PR and CLBR are similar in women with recently surgically treated minimal to mild and in women with unexplained infertility. These data are in contrast with earlier reports that demonstrated a significantly lower PR after COH, with or without IUI, in patients with surgically untreated minimal to mild when compared with those with unexplained infertility (11, 12). Furthermore, in our study, the 20% PR per cycle after COH and IUI in women with minimal to mild was higher than the 6% (11) or 13% (12) PRs reported previously. The fact that there was no surgical treatment of before therapy with COH and IUI in these studies (11, 12) could contribute to these lower PRs. Collectively, these data suggest that surgical treatment before COH and IUI restores the clinical PR after COH and IUI in women with minimal to mild to the same level as reached in women with unexplained infertility. To our knowledge, only one other investigation (17) has evaluated the outcome of superovulation and IUI in patients with treated minimal to mild compared with those with unexplained infertility, but it concluded that women with had lower PRs than those with unexplained infertility. However, that study (17) cannot be compared with our study because the patients were older (average age, 37.4 years) than in our study and included not only patients with minimal or mild but also a subgroup with mild adnexal disease, including distal tubal disease and adnexal adhesions, which are known to cause a less favorable fertility prognosis (3). In our study, no statistical difference was found between the cumulative live-birth rate of patients with minimal and mild and unexplained infertility (70.2%, 68.2%, and 66.5%, respectively). In another retrospective cohort study performed at LUFC (18), a lower CLBR of 52.8% was found within four cycles of COH and IUI in couples with normozoospermia. A possible explanation for the discrepancies in results is the difference in patient selection in the study. The previously published trial (18) evaluated the CLBR in a group of women whose male partners had normozoospermia, but the group was heterogeneous with respect to the severity of, abnormal ovulatory function, abnormal tuboovarian anatomy, and other factors (18). A longer duration of infertility (Table 1) was observed in patients with minimal when compared with couples with unexplained infertility. This may be explained by our policy of expectant management (after full infertility workup before surgery) during 6 to 12 months after surgical treatment of to allow spontaneous conception; it was demonstrated in a multicenter, Canadian randomized controlled study that surgical removal of endometriotic lesions and -related adhesions in women with minimal to mild increased the spontaneous PR (8). This longer duration of infertility in the group when compared to the unexplained infertility group is unlikely to have influenced the results significantly. Indeed, any bias introduced would have favored a lower PR in the group than in the unexplained infertility group Fertility and Sterility 569
5 TABLE 2 Clinical PR and live-birth rate per cycle after treatment with COH and IUI in women with and women with unexplained infertility. Characteristic Total Minimal mild Minimal Mild Unexplained infertility Patients Cycles No. of pregnancies/no. 20% 20% 21% 19% 20% of cycles (53/259) (28/137) (21/100) (7/37) (25/122) No. of implantations/ 23% 23% 25% 19% 23% no. of cycles (60/259) (32/137) (25/100) (7/37) (28/122) No. of multiple pregnancies/no. of 11% 14% 19% 0 12% clinical pregnancies (6/53) (4/28) (3/21) (0/7) (3/25) Twins 0/7 3/25 Triplets 2/21 0/7 0/25 1/21 a No. of miscarriages/ no. of clinical 11% 11% 19% 0 12% pregnancies (6/53) (3/28) (3/21) (0/7) (3/25) Ectopic pregnancies/ 4% 4% 5% 0 4% clinical pregnancies (2/53) (1/28) (1/21) (0/7) (1/25) No. of live births/no. of 85% 85% 81% 100% 84% pregnancies (45/53) (24/28) (17/21) (7/7) (21/25) No. of multiple live births/no. of live 11% 7% 9% 0 12% births (5/45) (2/28) (2/21) (0/7) (3/25) a Single delivery was achieved after embryo reduction of a triplet pregnancy. Werbrouck. COH and IUI are effective in. Fertil Steril FIGURE 2 Cumulative birth rate. because it is well known that the PR after fertility treatment is negatively correlated with the duration of infertility. In our study, the implantation rate per cycle was 23%; it was similar in women with and in women with unexplained infertility. In contrast, a higher implantation rate of 44% was observed in patients with unexplained infertility in a randomized prospective trial (11) because the multiple pregnancy rate per cycle was much higher in that study (11) than in our study (11%). The multiple pregnancy rate in our study is comparable to the rate reported in our previously published study (18), still higher than in our current practice (19), but lower than what is generally reported after COH with gonadotrophins and IUI (20 22). This observation, together with the high cumulative livebirth rate of nearly 70% within four cycles, suggest that COH and IUI should be a first line of treatment in patients who have not become pregnant within 6 months to 1 year after surgical treatment of minimal to mild and who have no other fertility reducing factors. Werbrouck. COH and IUI are effective in. Fertil Steril REFERENCES 1. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of : Fertil Steril 1997;67: Bérubé S, Marcoux S, Langevin M, Maheux R, and the Canadian Collaborative Group on Endometriosis. Fecundity of infertile women with minimal or mild and women with unexplained infertility. Fertil Steril 1998;69: Werbrouck et al. COH and IUI are effective in Vol. 86, No. 3, September 2006
6 3. D Hooghe TM, Debrock S, Hill JA, Meuleman C. Endometriosis and subfertility: is the relationship resolved? Semin Reprod Med 2003; 21(2): Nowroozi K, Chase JS, Check JH, Wu CH. The importance of laparoscopic coagulation of mild in infertile women. Int J Fertil 1987;32: Paulson JD, Asmar P, Saffan DS. Mild and moderate. Comparison of treatment modalities for infertile couples. J Reprod Med 1991;62: Schenken RS, Malinak LR. Conservative versus expectant management for the infertile patient with mild. Fertil Steril 1982;37: Arumugam K, Urquhart R. Efficacy of laparoscopic electrocoagulation in infertile patients with minimal or mild. Acta Obstet Gynecol Scand 1991;70: Marcoux S, Maheux R, Bérubé S, for the Canadian Collaborative Group on Endometriosis. Laparoscopic surgery in infertile women with minimal or mild. N Eng J Med 1997;337: Tummon IS, Asher LJ, Martin JSB, Tulandi T. Randomized controlled trial of superovulation and insemination for infertility with minimal or mild. Fertil Steril 1997;68: Deaton JL, Gibson M, Blackmer KM, Nakajima ST, Badger GJ, Brumsted JR. A randomised, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected. Fertil Steril 1990;54(6): Omland AK, Tanbo T, Dale PO, Abyholm TA. Artificial insemination by husband in unexplained infertility compared with infertility associated with peritoneal. Hum Reprod 1998;13(9): Nuoja-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprd 1999;14(3): Noyes RW, Hertwig AT, Rock T. Dating the endometrial biopsy. Fertil Steril 1950;1: World Health Organization. Laboratory manual for the examination of human semen and semen-cervical mucus interaction. 3rd ed. New York: Cambridge University Press, 1992: World Health Organization. Laboratory manual for the examination of human semen and semen-cervical mucus interaction. 4th ed. New York: Cambridge University Press, 1999: Singh M, Goldberg J, Falcone T, Nelson D, Pasqualotto E, Attaran M, Agarwal A. Superovulation and intrauterine insemination in cases of treated mild pelvic disease. J Assist Reprod Genet 2001;18: Yao MWM, Schust DJ. Infertility. In: Berek JS, ed. Novak s gynecology. 13th ed. Philadelphia: Williams & Wilkins, 2002: Spiessens C, Vanderschueren D, Meuleman C, D Hooghe T. Isolated teratozoospermia and intrauterine insemination. Fertil Steril 2003;80(5): Vermeylen AM, D Hooghe T, Debrock S, Meeuwis L, Meuleman C, Spiessens C. The type of catheter has no impact on the pregnancy rate after IUI: a randomised study. Hum Reprod. Published online May 16, Dodson WC, Haney AF. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility. Fertil Steril 1991; 55: Dickey RP, Olar TT, Taylor SN, Curole DN, Rye PH. Relationship of follicle number and other factors to fecundability and multiple pregnancy in clomiphene citrate-induced intrauterine insemination cycles. Fertil Steril 1992;57: Nulsen JC, Walsh S, Dumez S, Metzger DA. A randomised longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. Obstet Gynecol 1993;82: Fertility and Sterility 571
Is the endometriosis recurrence rate increased after ovarian hyperstimulation?
Is the endometriosis recurrence rate increased after ovarian hyperstimulation? Thomas M. D Hooghe, M.D., Ph.D., Bénédicte Denys, M.D., Carl Spiessens, Ph.D., Christel Meuleman, M.D., and Sophie Debrock,
More informationInfertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations
Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should
More informationIs the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion
F, V & V IN OBGYN, 2010, MONOGRAPH: 36-41 Artificial insemination Is the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion Arne SUNDE 1, Jarl
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationInfertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary
Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that
More informationOriginal Article. Fauzia HaqNawaz 1*, Saadia Virk 2, Tasleem Qadir 3, Saadia Imam 3, Javed Rizvi 2
Original Article Comparison of Letrozole and Clomiphene Citrate Efficacy along with Gonadotrophins in Controlled Ovarian Hyperstimulation for Intrauterine Insemination Cycles Fauzia HaqNawaz 1*, Saadia
More informationUnderstanding Infertility, Evaluations, and Treatment Options
Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly
More informationCLINICAL ASSISTED REPRODUCTION
Journal of Assisted Reproduction and Genetics, Vol. 17, No. 4. 2000 CLINICAL ASSISTED REPRODUCTION CLINICAL ASSISTED REPRODUCTION Effect of Clinical and Semen Characteristics on Efficacy of Ovulatory Stimulation
More informationK.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1
Human Reproduction vol.12 no.10 pp.2162 2166, 1997 Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and
More information5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle
Infertility FINANCIAL DISCLOSURE I HAVE NO FINANCIAL INTEREST IN ANY OF THE PRODUCTS MENTIONED IN MY PRESENTATION Bryan K. Rone, M.D. University of Kentucky Obstetrics and Gynecology I AM RECEIVING COMPENSATION
More informationRecent Developments in Infertility Treatment
Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationSurgical Management of Endometriosis associated Infertility
Surgical Management of Endometriosis associated Infertility Dr. Ingrid Lok Specialist in Obstetrics and Gynaecology (Honorary Clinical Associate Professor, CUHK) HA commission training 24.2.2014 Endometriosis
More informationRelation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy
Relation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy Aseel Mosa Jabber M.SC.G.O. The department of Obstetrics and Gynecology, Faculty of Medicine Thi-qar university
More informationThe prognostic factors for pregnancy after gonadotropin-induced controlled ovarian stimulation therapy with intrauterine insemination cycles
Available online at www.medicinescience.org ORIGINAL RESEARCH Medicine Science International Medical Journal Medicine Science 2018; ( ): The prognostic factors for pregnancy after gonadotropin-induced
More informationInfertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem?
Infertility (female factors). In another one third of cases, infertility is due to the man (male factors). The remaining cases are caused by a mixture of male and female factors or by unknown factors.
More informationIndian Journal of Basic and Applied Medical Research; September 2015: Vol.-4, Issue- 4, P
Original article: To study post intrauterine insemination conception rate among infertile women with polyp and women with normal uterine endometrium cavity 1Dr. Archana Meena, 2 Dr. Renu Meena, 3 Dr. Kusum
More informationInfertility. Thomas Lloyd and Samera Dean
Infertility Thomas Lloyd and Samera Dean Infertility Definition Causes Referral criteria Assisted reproductive techniques Complications Ethics What is infertility? Woman Reproductive age Has not conceived
More informationIntrauterine insemination treatment in subfertility: an analysis of factors affecting outcome
Human Reproduction vol.14 no.3 pp.698 703, 1999 Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome Sinikka Nuojua-Huttunen 1,4, Candido Tomas 2, Risto Bloigu
More informationAdvanced semen analysis: a simple screening test to predict intrauterine insemination success
FERTILITY AND STERILITY VOL. 71, NO. 3, MARCH 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Advanced semen analysis:
More informationInfertility: A Generalist s Perspective
Infertility: A Generalist s Perspective Learning Objectives Fertility and Lifestyle: Patient education Describe the basic infertility workup Basic treatment strategies unexplained Heather Huddleston, MD
More informationFollicular diameters in conception cycles with and without multiple pregnancy after stimulated ovulation induction
Human Reproduction Page 1 of 5 Hum. Reprod. Advance Access published December 17, 2004 doi:10.1093/humrep/deh677 Follicular diameters in conception cycles with and without multiple pregnancy after stimulated
More informationAssessment of the value of ultrasound monitoring and doubling of insemination in clomiphene citrate stimulated IUI cycles
Middle East Fertility Society Journal Vol. 9, No. 1, 2004 Copyright Middle East Fertility Society Assessment of the value of ultrasound monitoring and doubling of insemination in clomiphene citrate stimulated
More informationIntrauterine donor insemination in single women and lesbian couples: a comparative study of pregnancy rates
Human Reproduction vol.15 no.3 pp.621625, 2000 Intrauterine donor insemination in single women and lesbian couples: a comparative study of pregnancy rates I.Ferrara 1, R.Balet 2 and J.G.Grudzinskas 1,2,3
More informationComparison of the effectiveness of single intrauterine insemination (IUI) versus double IUI per cycle in infertile patients
FERTILITY AND STERILITY VOL. 80, NO. 3, SEPTEMBER 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Comparison of the effectiveness
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationCancer Risks of Ovulation Induction
Cancer Risks of Ovulation Induction 5th World Congress on Ovulation Induction September 13-15, 2007 Louise A. Brinton, Ph.D. National Cancer Institute Rockville, Maryland, USA Ovulation Induction and Cancer
More informationClinical Study Fallopian Tube Sperm Perfusion in Treatment of Nontubal Subfertility: Is It Crucial Step prior to ART?
International Scholarly Research Network ISRN Obstetrics and Gynecology Volume 2011, Article ID 160467, 4 pages doi:10.5402/2011/160467 Clinical Study Fallopian Tube Sperm Perfusion in Treatment of Nontubal
More informationArticle Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination
RBMOnline - Vol 13. No 2. 2006 208-212 Reproductive BioMedicine Online; www.rbmonline.com/article/2334 on web 30 May 2006 Article Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine
More informationSuperovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony*
aes FERTILITY AND STERILITY Vol. 61, No.4, April 1994 Copyright ee) 1994 The American Fertility Society Printed on acid-free paper in U. S. A. r I Superovulation with human menopausal gonadotropins is
More informationUnexplained Infertility
Unexplained Infertility Kaylen M. Silverberg, M.D. Thomas C. Vaughn, M.D. Texas Fertility Center Austin, Texas Introduction Infertility is generally defined as the inability to conceive following one year
More informationIntrauterine Insemination - FAQs Q. How Does Pregnancy Occur?
Published on: 8 Apr 2013 Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur? A. The female reproductive system involves the uterus, ovaries, fallopian tubes, cervix and vagina. The female hormones,
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationReproductive Endocrinology and Infertility Rotation Objectives. Reproductive Endocrinology and Infertility Specialists
Reproductive Endocrinology and Infertility Rotation Objectives Reproductive Endocrinology and Infertility Specialists Terry O Grady M.D., FRCSC Sarah Healey M.D., FRCSC Deanna Murphy M.D., FRCSC Sean Murphy
More informationMedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL PA.018.MH Infertility- Treatment This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP (Not Covered) MedStar
More informationAssisted reproductive technology
Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo
More informationJMSCR Vol 04 Issue 12 Page December 2016
www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i12.77 Clinical Pregnancy Rate in Intra Uterine
More informationRisk factors for spontaneous abortion in menotropintreated
FERTILITY AND STERILITY Copyright ~ 1987 The American Fertility Society Vol. 48, No. 4, October 1987 Printed in U.S.A. Risk factors for spontaneous abortion in menotropintreated women Michael Bohrer, M.D.*
More informationINFERTILITY: DIAGNOSIS, WORKUP AND MANAGEMENT FOR THE COMMUNITY PHYSICIAN
INFERTILITY: DIAGNOSIS, WORKUP AND MANAGEMENT FOR THE COMMUNITY PHYSICIAN Caitlin Dunne, MD, FRCSC Clinical Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics
More informationRealizing dreams booklet.indd 1 5/20/ :26:52 AM
Realizing dreams. 18891booklet.indd 1 5/20/2010 11:26:52 AM The Journey To Parenthood The first Gator Baby was born in 1988 through the in vitro fertilization program at the University of Florida. Since
More informationInfertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF
Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility
More informationCurrent Evidence On Infertility Treatment
Current Evidence On Infertility Treatment Mahmoud A.M. Abdel-Aleem Regina Kulier WHO/GFMER 2003 Problem of Infertility It is a state in which a couple, desirous of a child, cannot conceive after 12 months
More informationBleeding and spontaneous abortion after therapy for infertility
FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Bleeding and spontaneous
More informationInfertility for the Primary Care Provider
Infertility for the Primary Care Provider David A. Forstein, DO FACOOG Clinical Associate Professor Obstetrics and Gynecology University of South Carolina School of Medicine Greenville Disclosure I have
More informationPregnancy Outcome following Active Management of Endometriosis after Laparoscopy in Infertile Women A Prospective Cohort Study
ORIGINAL RESEARCH KERALA MEDICAL JOURNAL Pregnancy Outcome following Active Management of Endometriosis after Laparoscopy in Infertile Women A Prospective Cohort Study Anupama R KJK Hospital, Nalanchira,
More information2017 United HealthCare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017
More informationInfertility. F r e q u e n t l y A s k e d Q u e s t i o n s. Q: What causes infertility in men? A: Infertility in men is most often caused by:
Infertility Q: What is infertility? A: Infertility means not being able to get pregnant after one year of trying. Or, six months, if a woman is 35 or older. Women who can get pregnant but are unable to
More informationUnexplained infertility Evidence based management
Unexplained infertility Evidence based management Dr Mark Hamilton Consultant Gynaecologist NHS Grampian/University of Aberdeen m.hamilton@abdn.ac.uk www.iffs-reproduction.org @IntFertilitySoc Int@FedFertilitySoc
More informationManagement of Female infertility Tim Chang
Management of Female infertility Tim Chang www.drtchang.com.au Assess and manage as a couple because: 30% infertility male factor related emotional support Role of the physician 1) diagnose and treat the
More informationSurgery and Infertility
Surgery and Infertility Dr Phill McChesney BHB MBChB FRANZCOG MRMed CREI Laparoscopy Prior to Considering IVF Diagnostic Tubal Surgery Treatment of peritubal adhesions Reconstructive surgery Sterilization
More informationReproductive Testing: Less is More G. Wright Bates, Jr., M.D. Professor and Director Reproductive Endocrinology and Infertility Objectives
Reproductive Testing: Less is More G. Wright Bates, Jr., M.D. Professor and Director Reproductive Endocrinology and Infertility Objectives 1. Review definition of infertility and impact of age 2. Stress
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationEndometriosis and infertility
FERTILITY AND STERILITY VOL. 81, NO. 5, MAY 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Endometriosis and infertility
More informationOvulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age*
FERTILITY AND STERILITY Vol. 58, No.4, October 1992 Copyright It! 1992 The American Fertility Society Printed on acid-free paper in U. S.A. Ovulation induction in women age 40 and older: the importance
More informationLinda M. Chafi'kin, M.D. John C. Nulsen, M.D. Anthony A. Luciano, M.D. Deborah A. Metzger, Ph.D., M.D.t
FRTILITY AND STRILITY Copyright 1991 The American Fertility Society Vol. 55, No.2, February 1991 Printed on acid-free paper in U.S.A. A comparative analysis of the cycle fecundity rates associated with
More informationEndometriosis and infertility
Endometriosis and infertility The Practice Committee of the American Society for Reproductive Medicine Birmingham, Alabama Women with endometriosis typically present with pelvic pain, infertility or an
More informationMinimal stimulation protocol for use with intrauterine insemination in the treatment of infertility Dhaliwal L K, Sialy R K, Gopalan S, Majumdar S
Minimal stimulation protocol for use with intrauterine insemination in the treatment of infertility Dhaliwal L K, Sialy R K, Gopalan S, Majumdar S Record Status This is a critical abstract of an economic
More informationThe evidence for insemination versus intercourse or IVF
To inseminate or not: that s the question! The evidence for insemination versus intercourse or IVF B.Cohlen, Genk 2009 There are believers and non-believers Ovarian stimulation protocols (anti-oestrogens,
More informationFertility Treatment: Do not be Distracted
Fertility Treatment: Do not be Distracted Fertility Treatment: do not be distracted by worthless recommendation Fertility Treatment: Do not be Distracted When contemplating options for fertility treatment
More informationChapter 1. Chapter 2. Chapter 3
Summary To perform IUI some conditions are required. This includes 1) a certain amount of progressively motile spermatozoa, 2) the presence of ovulation, 3) the presence of functional fallopian tubes,
More informationPredictive Factors for Pregnancy after Intrauterine Insemination: A Retrospective Study of Factors Affecting Outcome
Azadeh Pravin Patel et al Original Article 10.5005/jp-journals-10006-1404 Predictive Factors for Pregnancy after Intrauterine Insemination: A Retrospective Study of Factors Affecting Outcome 1 Azadeh Pravin
More informationComparison of single versus double intra uterine insemination
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pathak B. Int J Reprod Contracept Obstet Gynecol. 2017 Dec;6(12):5277-5281 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20175091
More informationAssisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION
( C 2005) DOI: 10.1007/s10815-005-4912-8 Assisted Reproduction Clomiphene citrate induced ovulation and intrauterine insemination: effect of timing of human chorionic gonadotropin injection in relation
More informationThe role of laparoscopy in intrauterine insemination: a prospective randomized reallocation study
Human Reproduction Vol.20, No.11 pp. 3225 3230, 2005 Advance Access publication July 8, 2005. doi:10.1093/humrep/dei201 The role of laparoscopy in intrauterine insemination: a prospective randomized reallocation
More informationNaProTechnology. An Integrated Approach to Infertility. Tracy Parnell. Geneva 2005
NaProTechnology An Integrated Approach to Infertility Tracy Parnell Geneva 2005 Outline Scientific foundations Illustrative case history Research Discussion and questions NPT Natural Procreative Technology(NPT)
More informationInfertility treatment other than ART. Dr. Prue Johnstone FRANZCOG MRepMed
Infertility treatment other than ART Dr. Prue Johnstone FRANZCOG MRepMed What is Subfertility? (not infertility!) Primary subfertility Absence of conception after 12 months of unprotected intercourse timed
More informationEVALUATING THE INFERTILE PATIENT-COUPLES. Stephen Thorn, MD
EVALUATING THE INFERTILE PATIENT-COUPLES Stephen Thorn, MD Overview The field of reproductive medicine continues to evolve rapidly by offering newer diagnostic testing and therapeutic options to improve
More informationFertility assessment and assisted conception
Fertility assessment and assisted conception Dr Geetha Venkat MD FRCOG Director Pulse Learning Women s health 14 September 2016 Disclosure statement Dr Venkat is a director of Harley Street Fertility Clinic.
More informationControlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study
Human Reproduction vol.13 no.6 pp.1553 1558, 1998 Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study Bernard J.Cohlen 1,3, Egbert R.te
More informationClomiphene citrate monitoring for intrauterine insemination timing: a randomized trial
OVULATION INDUCTION Clomiphene citrate monitoring for intrauterine insemination timing: a randomized trial Vivian Lewis, M.D., a John Queenan Jr., M.D., a Kathleen Hoeger, M.D., a Joanne Stevens, R.N.,
More informationMinimal stimulation achieves pregnancy rates comparable to human menopausal gonadotropins in the treatment of infertility*
FERTILITY AND STERILITY Copyright :Q' 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Minimal stimulation achieves pregnancy rates comparable to human menopausal
More informationwomen and in women who had not been exposed previously to spermatozoa. 3 In baboons, fecundity was also
Research REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY Fertility in women with minimal endometriosis compared with normal women was assessed by means of a donor insemination program in unstimulated cycles
More informationOvarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy
Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy M.E. Coccia, F. Cammilli, L. Ginocchini, F. Borruto* and F. Rizzello Dept Gynaecology Perinatology and Human
More informationWhich is the Best Protocol of Ovarian Stimulation Prior to Artificial Insemination by Donor
Journal of Reproduction & Contraception doi: 10.7669j.issn.1001-7844.2014.01.0041 2014 Mar.; 25(1):41-48 E-mail: randc_journal@163.com Which is the Best Protocol of Ovarian Stimulation Prior to Artificial
More informationChris Davies & Greg Handley
Chris Davies & Greg Handley Contents Definition Epidemiology Aetiology Conditions for pregnancy Female Infertility Male Infertility Shared infertility Treatment Definition Failure of a couple to conceive
More informationUtility of in vitro fertilization at diagnostic laparoscopy*
FERTILITY AND STERILITY Copyright" 1994 The American Fertility Society Printed on acid-free paper in U. S. A. Utility of in vitro fertilization at diagnostic laparoscopy* Paul R. Gindoff, M.D.t Jerry L.
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More informationImpact of Ovarian Endometrioma Per Se and Surgery on Ovarian Reserve and Pregnancy Rate in in Vitro Fertilization Cycles
1 st SEUD Meeting, 9 May 2015, Paris, France Impact of Ovarian Endometrioma Per Se and Surgery on Ovarian Reserve and Pregnancy Rate in in Vitro Fertilization Cycles ENDOMETRIOSIS ovarian endometrioma
More informationInfertility DR. RAHUL BEVARA
Infertility DR. RAHUL BEVARA Definitions Infertility is defined as the inability to conceive after one year of unprotected coitus. Affects 10-15% of couples Primary Infertility, that is inability to conceive
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationHana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang
Original Article Obstet Gynecol Sci 2015;58(6):481-486 http://dx.doi.org/10.5468/ogs.2015.58.6.481 pissn 2287-8572 eissn 2287-8580 Effect of second-line surgery on in vitro fertilization outcome in infertile
More informationBulent Urman, M.D.* Margo R. Fluker, M.D. Basil Ho Yuen, M.B., Ch.B.t
FERTILITY AND STERILITY Copyright c 1992 The American Fertility Society Vol. 57, No.6, June 1992 Printed on acid-free paper in U.S.A. The outcome of in vitro fertilization and embryo transfer in women
More informationSubfertility & prognostic factors & intrauterine insemination
Subfertility & prognostic factors & intrauterine insemination N.Cem FIÇICIOĞLU, M.D., Ph.D. Professor and Director Department of Gynecology & Obstetrics and IVF Center Yeditepe University, School of Medicine
More informationLaboratoires Genevirer Menotrophin IU 1.8.2
Important missing information VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Infertility is when a woman cannot get pregnant (conceive) despite having regular unprotected sexual
More informationInfertility INA S. IRABON, MD, FPOGS, FPSRM, FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY
Infertility INA S. IRABON, MD, FPOGS, FPSRM, FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY To download lecture deck Reference Comprehensive Gynecology 7 th edition, 2017 (Lobo
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationLow Dose hmg As a First choice for Ovarian Stimulation in IUI cycles
Low Dose hmg As a First choice for Ovarian Stimulation in IUI cycles aslan, M.D Department of Obstetrics & Gynecology, Cairo University Abstract Objective: to compare pregnancy rates following low dose
More informationJournal of American Science 2013;9(12) Mohamed Elkadi, Amr Elhelaly, Ahmed Ibrahim, Shereen Abdelaziz
Clomiphene Citrate Alone or Followed by Human Chorionic Gonadotropin In Induction of Ovulation. Mohamed Elkadi, Amr Elhelaly, Ahmed Ibrahim, Shereen Abdelaziz Department of Obstetrics and Gynecology Ain
More informationUse of donor semen in the treatment of
Use of donor semen in the treatment of male infertility Where is the evidence? Max H.J.M. Curfs Isala clinics Zwolle, The Netherlands Strength of evidence Systematic review Meta-analysis RCT 1A 1A 1B
More informationResearch and Health Policy Studies, Tufts-New England Medical Center, Boston, Massachusetts
Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis Ioannis P. Kosmas, M.D., a Athina
More informationType of intervention Treatment. Economic study type Cost-effectiveness analysis.
Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness Gerli S, Casini M L, Unfer V, Costabile L, Bini V,
More informationCauses of Infertility and Treatment Options
Causes of Infertility and Treatment Options Dr Mrs.Kiran D. Sekhar Former vice President-FOGSI Former Chairperson- Genetics and Foetal medicine-fogsi Founder and Medical Director-Kiran Infertility centre
More informationReproductive Endocrinology & Infertility Glossary
Reproductive Endocrinology & Infertility Glossary The following is a glossary of terms you may hear during your association with the University of Mississippi Health Care's reproductive endocrinology and
More informationINFERTILITY CAUSES. Basic evaluation of the female
INFERTILITY Infertility is the inability to conceive after 12 months of unprotected intercourse. There are multiple causes of infertility and a systematic way to evaluate the condition. Let s look at some
More informationF.Zayed 1 ' 3, E.A.Lenton 1 ' 2 and I.D.Cooke 2
Human Reproduction vol.12 no. 11 pp.2408-2413, 1997 Comparison between stimulated in-vitro fertilization and stimulated intrauterine insemination for the treatment of unexplained and mild male factor infertility
More informationAMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE INFERTILITY: AN OVERVIEW A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the
More informationManaging infertility when adenomyosis and endometriosis co-exist
Managing infertility when adenomyosis and endometriosis co-exist Jinhua Leng Beijing,China Endometriosis Endometriosis (EM) is a common, benign, ovary hormone-dependent gynecologic disorder which affects
More informationEFFECTS OF SPERM MORPHOLOGY AND TOTAL MOTILE SPERMATOZOA NUMBER ON THE RATE OF PREGNANCY THROUGH ARTIFICIAL INSEMINATION
Acta Medica Mediterranea, 2018, 34: 883 EFFECTS OF SPERM MORPHOLOGY AND TOTAL MOTILE SPERMATOZOA NUMBER ON THE RATE OF PREGNANCY THROUGH ARTIFICIAL INSEMINATION XUAN-CHENG MAI, LEI DING, YONG-FANG XU,
More informationTimur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating
More information* Present address: Foothills Hospital, Calgary, Alberta, Canada.
FERTILITY AND STERILITY Copyright 1993 The American Fertility Society Vol. 59, No. 6, June 1993 Printed on acid-free paper in U.S.A. A randomized trial of in vitro fertilization versus conventional treatment
More information